Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
von Hippel-Lindau Tumor Suppressor, Hypoxia-Inducible Factor-1, and Tumor Vascularization — Huafeng Zhang (2009) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
von Hippel-Lindau Tumor Suppressor, Hypoxia-Inducible Factor-1, and Tumor Vascularization
Shared by
Gregg L. Friedman
Johns Hopkins University
von Hippel-Lindau Tumor Suppressor, Hypoxia-Inducible Factor-1, and Tumor Vascularization
Chapter In A Book
2009
en
Authors
HZ
Huafeng Zhang
Gregg L. Friedman
Johns Hopkins University
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2006
Hypoxia-Inducible Factor-1-Dependent Repression of <i>E-cadherin</i> in von Hippel-Lindau Tumor Suppressor–Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B
Balaji Krishnamachary
,
David Zagzag
,
Hideko Nagasawa
,
Karin Rainey
,
Hiroaki Okuyama
,
Jin Hyen Baek
,
Gregg L. Friedman
Article
2009
Regulation of Vascularization by Hypoxia‐Inducible Factor 1
Gregg L. Friedman
Article
2019
Hypoxia-inducible factors activation protects mitochondria function and prevents albuminuria in kidney-specific diabetic von Hippel-Lindau deficient mice
Carla Carvalho
,
Tomas A. Schiffer
,
Xiaowei Zheng
,
Jacob Grünler
,
Susanne Karlsson
,
Massimiliano Mazzone
,
Peter Carmeliet
,
Peter Hansell
,
Sergiu‐Bogdan Catrina
,
Malou Friederich
,
Fredrik Palm
Article
2015
Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization
Gregg L. Friedman
Article
2008
Regulation of Ischemia-Induced Vascularization by Hypoxia-Inducible Factor 1
Gregg L. Friedman
Discussion(0)
No comments yet. Be the first to comment.